DZ1471A1 - Dérivés du (n-méthyl-n-alcoyl)-amino-3 méthoxyméthylene-2 propane 1-0l, ainsi que leur procédé de préparation. - Google Patents

Dérivés du (n-méthyl-n-alcoyl)-amino-3 méthoxyméthylene-2 propane 1-0l, ainsi que leur procédé de préparation.

Info

Publication number
DZ1471A1
DZ1471A1 DZ900227A DZ900227A DZ1471A1 DZ 1471 A1 DZ1471 A1 DZ 1471A1 DZ 900227 A DZ900227 A DZ 900227A DZ 900227 A DZ900227 A DZ 900227A DZ 1471 A1 DZ1471 A1 DZ 1471A1
Authority
DZ
Algeria
Prior art keywords
methoxymethylene
propane
derivatives
amino
alkyl
Prior art date
Application number
DZ900227A
Other languages
English (en)
Inventor
Pierre Braquet
Colette Broquet
Benedicte Vandamme
Nicolas Paola Principe
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Application granted granted Critical
Publication of DZ1471A1 publication Critical patent/DZ1471A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/10—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20—Quaternary compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
DZ900227A 1989-12-19 1990-12-16 Dérivés du (n-méthyl-n-alcoyl)-amino-3 méthoxyméthylene-2 propane 1-0l, ainsi que leur procédé de préparation. DZ1471A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898928580A GB8928580D0 (en) 1989-12-19 1989-12-19 3-(n-methyl-n-alkylamino)-methoxymethyl-propanol phosphocholine derivatives

Publications (1)

Publication Number Publication Date
DZ1471A1 true DZ1471A1 (fr) 2004-09-13

Family

ID=10668132

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ900227A DZ1471A1 (fr) 1989-12-19 1990-12-16 Dérivés du (n-méthyl-n-alcoyl)-amino-3 méthoxyméthylene-2 propane 1-0l, ainsi que leur procédé de préparation.

Country Status (32)

Country Link
US (1) US5118674A (fr)
JP (1) JPH04208256A (fr)
KR (1) KR910011759A (fr)
AR (1) AR246742A1 (fr)
AT (1) AT400333B (fr)
AU (1) AU630056B2 (fr)
BE (1) BE1004089A3 (fr)
CA (1) CA2032224C (fr)
CH (1) CH681624A5 (fr)
DE (1) DE4040685A1 (fr)
DK (1) DK171298B1 (fr)
DZ (1) DZ1471A1 (fr)
ES (1) ES2023607A6 (fr)
FI (1) FI906162A (fr)
FR (2) FR2656797B1 (fr)
GB (2) GB8928580D0 (fr)
GR (1) GR1000893B (fr)
HK (1) HK118093A (fr)
IE (1) IE65888B1 (fr)
IN (1) IN173969B (fr)
IT (1) IT1243412B (fr)
LU (1) LU87853A1 (fr)
MA (1) MA22013A1 (fr)
MY (1) MY104781A (fr)
NL (1) NL9002582A (fr)
NO (1) NO177146C (fr)
NZ (1) NZ236213A (fr)
OA (1) OA09475A (fr)
PT (1) PT96265B (fr)
SE (1) SE469383B (fr)
TN (1) TNSN90152A1 (fr)
ZA (1) ZA909663B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551623B1 (en) 1993-09-09 2003-04-22 Lorus Therapeutics Inc. Immunomodulating compositions from bile
NZ273258A (en) 1993-09-09 2000-01-28 Lorus Therapeutics Inc Immunomodulator composition with components less than 3000 D that are extractable from bile, stimulate monocytes and macrophages and modulate TNF
NZ302638A (en) 1995-03-16 2001-04-27 Imutec Pharma Inc Immunomodulating composition from bile for the treatment of immune system disorders
US20040101569A1 (en) * 1996-05-16 2004-05-27 Lorus Therapeutics Inc. Immunomodulating compositions from bile
DE19711758C2 (de) * 1997-03-21 2003-06-18 Degussa Verfahren zur Herstellung von 1,3-Dioxanverbindungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732263A1 (de) * 1977-07-16 1979-02-01 Schuler Gmbh L Vorrichtung zum herstellen einer sicke am umfang eines hohlzylinders
DE2820893C2 (de) * 1978-05-12 1986-02-20 A. Nattermann & Cie GmbH, 5000 Köln Strukturanaloga von natürlichen Phospholipiden und Verfahren zur Herstellung dieser Verbindungen
US4737518A (en) * 1984-04-03 1988-04-12 Takeda Chemical Industries, Ltd. Lipid derivatives, their production and use
WO1989007099A1 (fr) * 1988-02-05 1989-08-10 Schering Corporation Glycerol 2,2-disubstitue et composes analogues au glycerol, compositions et modes d'utilisation
JP2534893B2 (ja) * 1988-06-24 1996-09-18 日本ケミファ株式会社 新規なグリセリン誘導体およびその誘導体を含有する血小板凝集抑制剤
DE3906952A1 (de) * 1989-03-04 1990-09-06 Boehringer Mannheim Gmbh (3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel
GR1000688B (el) * 1989-12-22 1992-10-08 Sod Conseils Rech Applic Μεθοδος παρασκευης παραγωγων γλυκερινης.

Also Published As

Publication number Publication date
NO905373L (no) 1991-06-20
MA22013A1 (fr) 1991-07-01
GB9027421D0 (en) 1991-02-06
NO905373D0 (no) 1990-12-12
GB2239239A (en) 1991-06-26
CH681624A5 (fr) 1993-04-30
BE1004089A3 (fr) 1992-09-22
FR2656307A1 (fr) 1991-06-28
OA09475A (fr) 1992-11-15
HK118093A (en) 1993-11-12
PT96265A (pt) 1991-09-30
NL9002582A (nl) 1991-07-16
MY104781A (en) 1994-05-31
GB8928580D0 (en) 1990-02-21
FI906162A (fi) 1991-06-20
IN173969B (fr) 1994-08-13
ATA259590A (de) 1995-04-15
GR1000893B (el) 1993-03-16
FR2656307B1 (fr) 1992-09-18
DK171298B1 (da) 1996-08-26
SE469383B (sv) 1993-06-28
IT1243412B (it) 1994-06-10
NO177146B (no) 1995-04-18
ZA909663B (en) 1991-09-25
DK299590A (da) 1991-06-20
IE904567A1 (en) 1991-06-19
DK299590D0 (da) 1990-12-18
SE9004039D0 (sv) 1990-12-18
US5118674A (en) 1992-06-02
TNSN90152A1 (fr) 1991-03-05
SE9004039L (sv) 1991-06-20
GB2239239B (en) 1993-06-02
CA2032224C (fr) 1996-12-10
FI906162A0 (fi) 1990-12-14
GR900100812A (en) 1992-05-12
JPH04208256A (ja) 1992-07-29
IT9022438A0 (it) 1990-12-19
CA2032224A1 (fr) 1991-06-20
IE65888B1 (en) 1995-11-29
LU87853A1 (fr) 1991-05-07
AT400333B (de) 1995-12-27
AU6814290A (en) 1991-06-27
IT9022438A1 (it) 1992-06-19
FR2656797A1 (fr) 1991-07-12
ES2023607A6 (es) 1992-01-16
DE4040685A1 (de) 1991-06-20
AU630056B2 (en) 1992-10-15
KR910011759A (ko) 1991-08-07
FR2656797B1 (fr) 1992-09-18
AR246742A1 (es) 1994-09-30
NZ236213A (en) 1993-03-26
NO177146C (no) 1995-07-26
PT96265B (pt) 1998-06-30

Similar Documents

Publication Publication Date Title
OA05928A (fr) Nouveaux dérivés de céphalosporine, leur procédé de préparation.
NO2004007I2 (no) Nebivolol-hydroklorid er det genriske oaviibttit denfolgenderacemiske blanding:(+)Ä(SRRR)+(RSSS)Ü-of,9E'Äiminobis(metylen)ÜbisÄ6-fttO-3,4-dihydro-2H-1-benzopyran-2-metanolÜhydroklorid, som har den felgende struktur:
OA05914A (fr) Procédé de préparation de nouveaux dérivés de la taurine à activité neuro-musculaire renforcée.
DZ701A1 (fr) Nouveaux dérivés de la vinyl-6, furo-(3,4-c)-pyridine ainsi que leur procédé de préparation.
DZ743A1 (fr) Nouveaux dérivés de la furo-(3,4-c)-pyridine substitues en position 6, ainsi que leur procédé de préparation.
DZ702A1 (fr) Nouveaux dérivés de la carboxymethoxy-7 furo-(3,4-c)-pyridine ainsi que leur procédé de préparation.
DZ1618A1 (fr) Procédé de préparation de distilmats moyens.
OA09442A (fr) Dérivés de la thiéno-triazolo-diazépine, un procédé pour leur préparation et compositions thérapeutiques en contenant.
DZ1407A1 (fr) Dérivés d-substitués des n,n'-ditriméthoxybenzoylepipérazine ainsi que leur procédé de préparation.
DZ1414A1 (fr) Dérivés de la thiéno-triazolo-diazépine, ainsi qu'un procédé de préparation desdits composés.
OA06414A (fr) Nouveaux dérivés de benzofuranne, leur procédé de préparation et leur application en thérapeutique.
DZ1471A1 (fr) Dérivés du (n-méthyl-n-alcoyl)-amino-3 méthoxyméthylene-2 propane 1-0l, ainsi que leur procédé de préparation.
FR2692579B1 (fr) Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
OA09336A (fr) Dérivés du glycérol, un procédé de préparation de ces dérivés et des compositions thérapeutiques les contenant.
FR2384775A1 (fr) Derives de la morphine, leur procede de preparation et leur application comme medicament
FR2695645B1 (fr) Procédé de préparation de polyaminoborazines.
NO905364L (no) Fremgangsmaate ved fremstilling av alkansyrederivater.
DZ1365A1 (fr) Nouveaux dérivés de la carbonyl-2 n,n'-di-(triméthoxybenzoyle) pipérazine, ainsi que leur procédé depréparation.
FR2691464B1 (fr) Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments.
FR2653771B1 (fr) Procede de preparation de l'azt (azido-3'-desoxy-3'-thymidine) et de composes apparentes.
DZ1460A1 (fr) Nouveaux dérivés du sélénophèn ainsi que leur procédé de préparation.
DZ773A1 (fr) Nouveaux dérivés du pyrane ainsi que leur procédé de préparation.
DZ1366A1 (fr) Nouveaux dérivés de la méthoxycarbonyl-2 n,n'-di-(triméthoxybenzoyle) pipérazine, ainsi que leur procédé de préparation.
DZ1655A1 (fr) Dérivés de la benzofuranylimidazole ainsi que leurprocédé de préparation.
FR2705672B1 (fr) Procédé de préparation de nitrophénols.